A Randomized Study of Finite Androgen Ablation vs. Finite Androgen Ablation in Combination with Abiraterone Acetate and Prednisone in Patients with Prostate Cancer Who Have PSA Progression After Prostatectomy and/or Radiotherapy
Latest Information Update: 31 Mar 2022
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisone (Primary) ; Bicalutamide; Degarelix; Flutamide; Goserelin; Leuprorelin; Nilutamide
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms FINITE
- 19 Feb 2022 Results presented at the 2022 Genitourinary Cancers Symposium
- 05 May 2020 Planned End Date changed from 1 Feb 2021 to 1 Feb 2025.
- 05 May 2020 Planned primary completion date changed from 1 Feb 2021 to 1 Feb 2025.